Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 24406748)

1.

Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.

Onishi T, Matsumoto Y, Hattori M, Obayashi Y, Nakamura K, Yano T, Horiguchi T, Iwashita H.

Neurosci Res. 2014 Mar;80:76-85. doi: 10.1016/j.neures.2013.12.006. Epub 2014 Jan 6.

PMID:
24406748
2.

Early behavioural markers of disease in P301S tau transgenic mice.

Scattoni ML, Gasparini L, Alleva E, Goedert M, Calamandrei G, Spillantini MG.

Behav Brain Res. 2010 Mar 17;208(1):250-7. doi: 10.1016/j.bbr.2009.12.002. Epub 2009 Dec 11.

PMID:
20004218
3.

Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.

Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, Martinez D, Joyce S, Trojanowski JQ, Lee VM.

J Neurosci. 2004 May 12;24(19):4657-67.

4.

Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.

Kulic L, Wollmer MA, Rhein V, Pagani L, Kuehnle K, Cattepoel S, Tracy J, Eckert A, Nitsch RM.

Neurobiol Aging. 2011 Oct;32(10):1827-38. doi: 10.1016/j.neurobiolaging.2009.10.014. Epub 2009 Nov 25.

PMID:
19942317
5.

Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.

Leroy K, Ando K, Héraud C, Yilmaz Z, Authelet M, Boeynaems JM, Buée L, De Decker R, Brion JP.

J Alzheimers Dis. 2010;19(2):705-19. doi: 10.3233/JAD-2010-1276.

PMID:
20110614
6.
7.

Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.

Gasparini L, Crowther RA, Martin KR, Berg N, Coleman M, Goedert M, Spillantini MG.

Neurobiol Aging. 2011 Mar;32(3):419-33. doi: 10.1016/j.neurobiolaging.2009.03.002. Epub 2009 Apr 7.

PMID:
19356824
9.

A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.

Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O.

Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21.

PMID:
18490011
10.

Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.

Polydoro M, Acker CM, Duff K, Castillo PE, Davies P.

J Neurosci. 2009 Aug 26;29(34):10741-9. doi: 10.1523/JNEUROSCI.1065-09.2009.

11.

Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau.

Bull ND, Guidi A, Goedert M, Martin KR, Spillantini MG.

PLoS One. 2012;7(4):e34724. doi: 10.1371/journal.pone.0034724. Epub 2012 Apr 4.

12.

Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease.

Belarbi K, Schindowski K, Burnouf S, Caillierez R, Grosjean ME, Demeyer D, Hamdane M, Sergeant N, Blum D, Buée L.

Curr Alzheimer Res. 2009 Apr;6(2):152-7.

13.

The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice.

Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS, Hogan AM, Xie SX, Ballatore C, Smith AB 3rd, Lee VM, Brunden KR.

J Neurosci. 2012 Mar 14;32(11):3601-11. doi: 10.1523/JNEUROSCI.4922-11.2012.

14.

Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration.

Melis V, Zabke C, Stamer K, Magbagbeolu M, Schwab K, Marschall P, Veh RW, Bachmann S, Deiana S, Moreau PH, Davidson K, Harrington KA, Rickard JE, Horsley D, Garman R, Mazurkiewicz M, Niewiadomska G, Wischik CM, Harrington CR, Riedel G, Theuring F.

Cell Mol Life Sci. 2015 Jun;72(11):2199-222. doi: 10.1007/s00018-014-1804-z. Epub 2014 Dec 19.

15.

Cell-mediated neuroprotection in a mouse model of human tauopathy.

Hampton DW, Webber DJ, Bilican B, Goedert M, Spillantini MG, Chandran S.

J Neurosci. 2010 Jul 28;30(30):9973-83. doi: 10.1523/JNEUROSCI.0834-10.2010.

16.

Brief update on different roles of tau in neurodegeneration.

Ittner A, Ke YD, van Eersel J, Gladbach A, Götz J, Ittner LM.

IUBMB Life. 2011 Jul;63(7):495-502. doi: 10.1002/iub.467. Review.

PMID:
21698753
17.

A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.

Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.

J Neurochem. 2011 Dec;119(6):1330-40. doi: 10.1111/j.1471-4159.2011.07532.x. Epub 2011 Nov 2.

PMID:
21992552
18.

Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.

Van der Jeugd A, Hochgräfe K, Ahmed T, Decker JM, Sydow A, Hofmann A, Wu D, Messing L, Balschun D, D'Hooge R, Mandelkow EM.

Acta Neuropathol. 2012 Jun;123(6):787-805. doi: 10.1007/s00401-012-0987-3. Epub 2012 Apr 25.

PMID:
22532069
19.

Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.

Brunden KR, Zhang B, Carroll J, Yao Y, Potuzak JS, Hogan AM, Iba M, James MJ, Xie SX, Ballatore C, Smith AB 3rd, Lee VM, Trojanowski JQ.

J Neurosci. 2010 Oct 13;30(41):13861-6. doi: 10.1523/JNEUROSCI.3059-10.2010.

20.

Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model.

Flunkert S, Hierzer M, Löffler T, Rabl R, Neddens J, Duller S, Schofield EL, Ward MA, Posch M, Jungwirth H, Windisch M, Hutter-Paier B.

Neurodegener Dis. 2013;11(4):194-205. doi: 10.1159/000338152. Epub 2012 Jul 10.

PMID:
22797329
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk